Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06239766 · ClinicalTrials.gov registry record
BC Risk Assessment Before Top Surgery
A clinical trial, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- 25
- Enrollment target
NCT06239766 is a clinical trial that has completed, run by Medical College of Wisconsin. The registered enrollment target is 25 participants.
The verdict
NCT06239766 has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The population of transgender and gender-diverse (TGD) persons in Wisconsin and the U.S. is steadily increasing. As this population grows, the number of individuals seeking gender-affirming therapies, including gender-affirming operations and gender-affirming hormone therapy, is also growing. An example of gender-affirming surgery is chest masculinization surgery, in which most breast tissue is removed in a person assigned female or intersex at birth to allow the chest to appear masculine. Gender-affirming chest masculinization surgery is not generally considered equivalent to an oncologic mastectomy, which aims to removal all breast tissue for future breast cancer reduction or current breast cancer treatment. The goals of this investigation are to 1) determine the percent of TGD persons considering chest masculinization surgery who have an elevated lifetime risk of breast cancer development and/or a pathogenic genetic mutation; 2) measure the percent who are at risk and choose to undergo risk-reducing mastectomies as part of chest masculinization surgery; and 3) assess and compare self-perceived breast cancer risk with calculated risk. The results of this study will substantially inform TGD patients and surgeons on the utility of personalized breast cancer risk assessment prior to chest masculinization surgery and the accuracy of self-perceived breast cancer risk in TGD persons.
Interventions
- DIAGNOSTIC_TEST Breast Cancer Risk Assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-03-15 |
| Est. Completion | 2024-02-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06239766
The ClinicalTrials.gov registry entry for NCT06239766 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Breast Cancer Risk Assessment is the first listed.
NCT06239766 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06239766 about?
NCT06239766 is a clinical study titled "BC Risk Assessment Before Top Surgery". The population of transgender and gender-diverse (TGD) persons in Wisconsin and the U.S. is steadily increasing. As this population grows, the number of individuals seeking gender-affirming therapies, including gender-affirming operations and gender-affirming hormone therapy, is also growing. An exa...
What is the current status of trial NCT06239766?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2023-03-15. Estimated completion is 2024-02-01.
What interventions are being tested in trial NCT06239766?
The interventions under investigation include: Breast Cancer Risk Assessment (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06239766?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.